Correlation Between VIRG NATL and Clearside Biomedical

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both VIRG NATL and Clearside Biomedical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining VIRG NATL and Clearside Biomedical into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between VIRG NATL BANKSH and Clearside Biomedical, you can compare the effects of market volatilities on VIRG NATL and Clearside Biomedical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in VIRG NATL with a short position of Clearside Biomedical. Check out your portfolio center. Please also check ongoing floating volatility patterns of VIRG NATL and Clearside Biomedical.

Diversification Opportunities for VIRG NATL and Clearside Biomedical

-0.53
  Correlation Coefficient

Excellent diversification

The 3 months correlation between VIRG and Clearside is -0.53. Overlapping area represents the amount of risk that can be diversified away by holding VIRG NATL BANKSH and Clearside Biomedical in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Clearside Biomedical and VIRG NATL is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on VIRG NATL BANKSH are associated (or correlated) with Clearside Biomedical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Clearside Biomedical has no effect on the direction of VIRG NATL i.e., VIRG NATL and Clearside Biomedical go up and down completely randomly.

Pair Corralation between VIRG NATL and Clearside Biomedical

Assuming the 90 days horizon VIRG NATL BANKSH is expected to generate 1.81 times more return on investment than Clearside Biomedical. However, VIRG NATL is 1.81 times more volatile than Clearside Biomedical. It trades about -0.07 of its potential returns per unit of risk. Clearside Biomedical is currently generating about -0.37 per unit of risk. If you would invest  3,967  in VIRG NATL BANKSH on September 27, 2024 and sell it today you would lose (247.00) from holding VIRG NATL BANKSH or give up 6.23% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

VIRG NATL BANKSH  vs.  Clearside Biomedical

 Performance 
       Timeline  
VIRG NATL BANKSH 

Risk-Adjusted Performance

2 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in VIRG NATL BANKSH are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. Despite nearly stable basic indicators, VIRG NATL is not utilizing all of its potentials. The newest stock price disturbance, may contribute to mid-run losses for the stockholders.
Clearside Biomedical 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Clearside Biomedical has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fragile performance in the last few months, the Stock's primary indicators remain comparatively stable which may send shares a bit higher in January 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

VIRG NATL and Clearside Biomedical Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with VIRG NATL and Clearside Biomedical

The main advantage of trading using opposite VIRG NATL and Clearside Biomedical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if VIRG NATL position performs unexpectedly, Clearside Biomedical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Clearside Biomedical will offset losses from the drop in Clearside Biomedical's long position.
The idea behind VIRG NATL BANKSH and Clearside Biomedical pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.

Other Complementary Tools

Stocks Directory
Find actively traded stocks across global markets
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated